Does EVOLOCUMAB Cause Injection site bruising? 4,409 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 4,409 reports of Injection site bruising have been filed in association with EVOLOCUMAB (REPATHA). This represents 3.0% of all adverse event reports for EVOLOCUMAB.
4,409
Reports of Injection site bruising with EVOLOCUMAB
3.0%
of all EVOLOCUMAB reports
1
Deaths
83
Hospitalizations
How Dangerous Is Injection site bruising From EVOLOCUMAB?
Of the 4,409 reports, 1 (0.0%) resulted in death, 83 (1.9%) required hospitalization, and 3 (0.1%) were considered life-threatening.
Is Injection site bruising Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 4,409 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Device use error (4,002)
What Other Drugs Cause Injection site bruising?
ETANERCEPT (7,734)
ADALIMUMAB (7,249)
TERIPARATIDE (4,405)
DUPILUMAB (4,332)
TIRZEPATIDE (2,665)
SECUKINUMAB (1,969)
DULAGLUTIDE (1,832)
HUMIRA (1,623)
EXENATIDE (1,299)
GLATIRAMER (1,197)
Which EVOLOCUMAB Alternatives Have Lower Injection site bruising Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE